Elismetrep
- Generic Name
- Elismetrep
- Drug Type
- Small Molecule
- Chemical Formula
- C27H21F3N2O5S
- CAS Number
- 1400699-64-0
- Unique Ingredient Identifier
- KIB8V5UR7D
- Background
Elismetrep is under investigation in clinical trial NCT02429102 (A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects).
Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy
Phase 2
Completed
- Conditions
- Painful Diabetic Peripheral Neuropathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 156
- Registration Number
- NCT05123196
- Locations
- 🇯🇵
Yachiyo Hospital, Anjo-City, Aichi, Japan
🇯🇵JUNEIKAI Medical Corporation Akaicho Clinic, Chiba-shi, Chiba, Japan
🇯🇵Medical Corporation Kouhoukai Takagi Hospital, Okawa-shi, Fukuoka, Japan
Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Mitsubishi Tanabe Pharma America Inc.
- Target Recruit Count
- 190
- Registration Number
- NCT03541200
- Locations
- 🇺🇸
Research Site, Seattle, Washington, United States
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
- First Posted Date
- 2016-02-05
- Last Posted Date
- 2016-03-24
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 28
- Registration Number
- NCT02675309
- Locations
- 🇬🇧
Investigational center, City name, United Kingdom
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 135
- Registration Number
- NCT02429102
- Locations
- 🇬🇧
Investigational center, City name, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath